Researchers developed a new model to predict the likelihood of critical illness in patients with connective-tissue disease-associated ILD.

A quantum-inspired AI approach can analyze millions of molecular features from small datasets, improving predictions, ...

Since 2017, Iason Gabriel has worked at the tech giant, trying to anticipate – and think through – the impact of AI. But as commercial and geopolitical pressures escalate, can ethicists make any ...

Cedars-Sinai Health Sciences University investigators developed an AI-based model that can identify hospitalized patients at ...

Medicine is rapidly evolving from statistical, evidence-based approaches to predictive, genotype-directed care, driven by ...

A new statistical framework could speed up the search for rare mutations that cause common diseases, helping researchers zero ...

A new algorithm could drive breakthroughs in understanding cancer, Alzheimer's disease and other potentially fatal conditions ...

Introduction Efficient preventive management of acute exacerbation of chronic obstructive pulmonary disease (COPD) is ...

Looking ahead to 2030, our model projects MMED could trade at an average price of $50.70, with a potential range between $38.03 and $63.38. This represents a potential 256.1% return from today's price ...

Cancer research has rapidly entered a data-rich era. Today, researchers can draw on whole-genome sequencing, single-cell atlases, longitudinal liquid biopsy ...

Looking ahead to 2030, our model projects TEM could trade at an average price of $98.76, with a potential range between $74.07 and $123.45. This represents a potential 69.4% return from today's price.